-
1
-
-
4444324909
-
Chemotherapy sensitivity and resistance assays: A systematic review
-
Samson D, Seidenfeld J, Ziegler K, et al: Chemotherapy sensitivity and resistance assays: A systematic review. J Clin Oncol 22:3618-3630, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3618-3630
-
-
Samson, D.1
Seidenfeld, J.2
Ziegler, K.3
-
2
-
-
4444267702
-
American Society of Clinical Oncology technology assessment: Chemotherapy sensitivity and resistance assays
-
Schrag D, Garewal H, Burstein H, et al: American Society of Clinical Oncology technology assessment: Chemotherapy sensitivity and resistance assays. J Clin Oncol 22:3631-3638, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3631-3638
-
-
Schrag, D.1
Garewal, H.2
Burstein, H.3
-
3
-
-
33846976600
-
-
Transcripts of the Medicare Coverage Advisory Committee MCAC
-
Transcripts of the Medicare Coverage Advisory Committee (MCAC) Meeting, Baltimore, MD, November 15-16, 1999
-
(1999)
Meeting, Baltimore, MD, November 15-16
-
-
-
4
-
-
0034082923
-
Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients
-
Nagourney RA, Link J, Blitzer J, et al: Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients. J Clin Oncol 18:2245-2249, 2000
-
(2000)
J Clin Oncol
, vol.18
, pp. 2245-2249
-
-
Nagourney, R.A.1
Link, J.2
Blitzer, J.3
-
5
-
-
0037229630
-
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients
-
Nagourney RA, Brewer C, Radecki R, et al: Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. Gynecol Oncol 88:35-39, 2003
-
(2003)
Gynecol Oncol
, vol.88
, pp. 35-39
-
-
Nagourney, R.A.1
Brewer, C.2
Radecki, R.3
-
6
-
-
3543054544
-
Gene expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
-
Holleman AH, Cheok MH, et al: Gene expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med, 351:533-542, 2004
-
(2004)
N Engl J Med
, vol.351
, pp. 533-542
-
-
Holleman, A.H.1
Cheok, M.H.2
-
8
-
-
0942278952
-
Comparison of outcomes in cancer patients treated within and outside clinical trials: Conceptual framework and structured review
-
Peppercorn JM, Weeks JC, Cook EF, Joffe S: Comparison of outcomes in cancer patients treated within and outside clinical trials: Conceptual framework and structured review. Lancet 363:263-270, 2004
-
(2004)
Lancet
, vol.363
, pp. 263-270
-
-
Peppercorn, J.M.1
Weeks, J.C.2
Cook, E.F.3
Joffe, S.4
-
9
-
-
2342644800
-
Why we're losing the war on cancer-And how to win it
-
March 22
-
Leaf C: Why we're losing the war on cancer-And how to win it. Fortune 149(6), March 22, 2004
-
(2004)
Fortune
, vol.149
, Issue.6
-
-
Leaf, C.1
|